SCHEMBL484450

SCHEMBL484450

CN(C)C1(c2ccc(F)cc2)CCC2(CCN(C(=O)Cc3ccc4c(c3)C(NC(=O)c3ccccc3Cl)CC4)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TAS1R3 Q7RTX0 6/20 0.40
TAS1R1 Q7RTX1 6/20 0.40
TAS1R2 Q8TE23 6/20 0.40
OPRM1 P35372 3/20 0.39
OPRL1 P41146 2/20 0.39
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
HTR2A P28223 1/20 0.37
KCNH2 Q12809 1/20 0.37
PDE10A Q9Y233 1/20 0.35
WDR5 P61964 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
KCNA5 P22460 1/20 0.35
HSD11B1 P28845 1/20 0.34
NR1I2 O75469 1/20 0.34
RORA P35398 1/20 0.34
RORC P51449 1/20 0.34
NR1H2 P55055 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484240 0.88 ALDH1A1 (0.42) ALDH1A1TAS1R3TAS1R1TAS1R2OPRM1
SCHEMBL484262 0.88 TAS1R3 (0.42) ALDH1A1TAS1R3TAS1R1TAS1R2HTR1A
SCHEMBL484271 0.85 ALDH1A1 (0.45) ALDH1A1TAS1R3TAS1R1TAS1R2OPRM1
SCHEMBL485370 0.80 CYP3A4 (0.45) ALDH1A1TAS1R3TAS1R1TAS1R2
SCHEMBL484565 0.80 ITGB3 (0.45) ALDH1A1TAS1R3TAS1R1TAS1R2
SCHEMBL2816651 0.80 TAS1R3 (0.45) ALDH1A1TAS1R3TAS1R1TAS1R2HTR1A
SCHEMBL484213 0.78 HTR1A (0.42) ALDH1A1TAS1R3TAS1R1TAS1R2HTR1A
SCHEMBL484791 0.77 ALDH1A1 (0.42) ALDH1A1TAS1R3TAS1R1TAS1R2WDR5
SCHEMBL485309 0.77 ITGB3 (0.46) ALDH1A1TAS1R3TAS1R1TAS1R2
SCHEMBL485180 0.77 KMT2A (0.41) ALDH1A1OPRM1OPRL1HTR1AHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885TAS1R3 339/4885TAS1R1 107/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN ALDH1A1 2086/4885TAS1R3 339/4885TAS1R1 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.